IRIS
CASSANO, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.749
EU - Europa 3.881
AS - Asia 3.367
SA - Sud America 487
Continente sconosciuto - Info sul continente non disponibili 442
AF - Africa 65
OC - Oceania 5
Totale 13.996
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.623
CN - Cina 1.147
SG - Singapore 1.134
IE - Irlanda 941
UA - Ucraina 635
RU - Federazione Russa 556
SE - Svezia 437
IT - Italia 424
BR - Brasile 403
HK - Hong Kong 304
FR - Francia 276
DE - Germania 226
VN - Vietnam 196
IN - India 192
FI - Finlandia 129
TR - Turchia 123
GB - Regno Unito 88
KR - Corea 80
CA - Canada 46
AT - Austria 44
BD - Bangladesh 35
ID - Indonesia 30
MX - Messico 28
AR - Argentina 24
NL - Olanda 23
PL - Polonia 20
IQ - Iraq 19
JP - Giappone 17
ZA - Sudafrica 17
BE - Belgio 16
MA - Marocco 14
EC - Ecuador 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
CO - Colombia 10
CL - Cile 9
EU - Europa 8
HN - Honduras 8
LT - Lituania 8
PK - Pakistan 8
PY - Paraguay 8
SA - Arabia Saudita 8
VE - Venezuela 8
CR - Costa Rica 7
CH - Svizzera 6
ES - Italia 6
BH - Bahrain 5
DK - Danimarca 5
KE - Kenya 5
PA - Panama 5
PE - Perù 5
PT - Portogallo 5
SV - El Salvador 5
TN - Tunisia 5
DZ - Algeria 4
GR - Grecia 4
GT - Guatemala 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
NI - Nicaragua 4
PH - Filippine 4
TH - Thailandia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
GP - Guadalupe 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AU - Australia 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
TV - Tuvalu 2
AL - Albania 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
HR - Croazia 1
IM - Isola di Man 1
Totale 13.546
Salva come PNG Salva come JPEG
Città #
Dublin 939
San Jose 915
Singapore 611
Chandler 536
Ashburn 463
Jacksonville 430
Dearborn 325
Hong Kong 303
Nyköping 291
Beijing 276
Nanjing 205
Dallas 201
Santa Clara 156
Council Bluffs 140
Columbus 116
Lauterbourg 104
Wilmington 104
New York 103
Princeton 100
The Dalles 84
Los Angeles 71
Nanchang 71
Ann Arbor 70
Moscow 63
San Mateo 63
Ho Chi Minh City 60
Helsinki 56
Boardman 50
Des Moines 49
Rome 49
Shenyang 47
Munich 45
Hebei 44
Phoenix 44
Tianjin 39
Hilden 36
Hanoi 35
Woodbridge 34
Jiaxing 32
São Paulo 31
Foggia 30
Kunming 30
Vienna 30
Agrolândia 29
Pune 29
Hangzhou 28
Jinan 28
Guangzhou 27
Bari 25
Seattle 20
Milan 19
Changsha 18
Chicago 17
Ningbo 17
Brooklyn 16
Brussels 16
Warsaw 16
Atlanta 15
Frankfurt am Main 15
Wuhan 15
Shanghai 14
Zhengzhou 14
Chennai 13
Haiphong 13
Dong Ket 12
Falls Church 12
Norwalk 12
Rio de Janeiro 12
San Severo 12
Tashkent 12
Tokyo 12
Toronto 11
Washington 11
Boston 10
Düsseldorf 10
Jakarta 10
Lanzhou 10
San Francisco 10
Auburn Hills 9
Denver 9
Houston 9
Johannesburg 9
New Providence 9
Orem 9
West Jordan 9
Naples 8
New Delhi 8
Philadelphia 8
Porto Alegre 8
Redwood City 8
Alexandria 7
Da Nang 7
Dhaka 7
Fresno 7
Hefei 7
Hudson 7
London 7
Nuremberg 7
Santeramo In Colle 7
Stockholm 7
Totale 8.214
Salva come PNG Salva come JPEG
Nome #
Use of mammalian target of rapamycin inhibitor for treating pathologies including neurodegenerative diseases (Alzheimer's disease), neuroinflammatory diseases and tumor diseases with neurological involvement, by intrathecal administration 216
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 185
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in wistar rats. 178
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 169
Biochemical and Neurobehavioral Profile of CHF2819, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease 165
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 164
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 163
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 162
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 162
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 161
Antinutritional effects of fumonisin B1 and pathophysiological consequences 159
Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats 157
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 157
Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels 156
Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects 156
Aberrant insulin signaling in Alzheimer's disease: current knowledge 154
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex 153
Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. 153
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 152
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 151
Novel codrugs with GABAergic activity for dopamine delivery in the brain 151
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 150
Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration 149
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 149
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 147
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles 145
Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor 143
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease 143
Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target 142
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder 141
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 140
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 140
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 140
Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring 138
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 138
CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor 136
Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice 136
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs 135
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons 135
Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. 134
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 133
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease 132
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 131
Astrocyte function is affected by aging and not Alzheimer's disease: A preliminary investigation in hippocampi of 3xTg-AD mice 131
Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence [Biomed. Pharmacother. 188 (2025) 118199] 130
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 130
Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring 128
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 128
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease: In Vitro and In Vivo Evidence 127
Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients 126
Prenatal Exposure to the CB1 Receptor Agonist Win 55,212-2 Causes Learning Disruption Associated With Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring 125
Role of the area postrema in the hypophagic effects of oleoylethanolamide 124
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress 123
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 123
Olfactory memory is impaired in a triple transgenic model of Alzheimer disease 123
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. 122
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 120
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress 120
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 120
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures 119
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm 119
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 119
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 118
Lung histopathological findings in COVID-19 disease - a systematic review 116
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 115
Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats 113
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 113
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: An in vivo study 113
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 113
Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide 112
Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide 112
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 110
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 110
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge-eating disorder 110
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard 109
Delta9-Tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons. Involvement of CB1 receptors 108
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin 107
Editorial: Dysmetabolism, obesity, and inflammation: Three prominent actors in the drama of major neuropsychiatric disorders 106
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 105
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. 103
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 103
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 102
The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: An in vivo microdialysis study in the awake rat 101
The effects of oleoylethanolamide on feeding behaviour involve hypothalamic oxytocin neurons 100
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 100
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 100
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease 99
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease 98
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 98
The Role of Toll-Like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 97
Neurochemical changes produced by CHF2819, a novel, orally active acetylcholinesterase inhibitor, in rat brain 96
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 96
Insulin signaling: An opportunistic target to minify risk of Alzheimer's disease 94
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 93
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus 93
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats 90
Effects of ENA713 and CHF2819, two anti-Alzheimer’s disease drugs, on rat amino acid levels 89
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 88
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 86
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice 86
Totale 12.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022459 0 0 0 8 39 14 12 38 89 76 30 153
2022/20232.350 202 96 96 158 115 230 39 194 1.104 23 46 47
2023/2024472 61 32 17 23 46 157 21 11 2 11 2 89
2024/20251.916 85 19 79 64 72 234 231 95 468 151 213 205
2025/20263.898 246 304 510 511 259 153 761 405 282 229 85 153
2026/20271.104 73 276 322 433 0 0 0 0 0 0 0 0
Totale 13.996